155 related articles for article (PubMed ID: 13679858)
1. Loss of expression of tropomyosin-1, a novel class II tumor suppressor that induces anoikis, in primary breast tumors.
Raval GN; Bharadwaj S; Levine EA; Willingham MC; Geary RL; Kute T; Prasad GL
Oncogene; 2003 Sep; 22(40):6194-203. PubMed ID: 13679858
[TBL] [Abstract][Full Text] [Related]
2. Tropomyosins of human mammary epithelial cells: consistent defects of expression in mammary carcinoma cell lines.
Bhattacharya B; Prasad GL; Valverius EM; Salomon DS; Cooper HL
Cancer Res; 1990 Apr; 50(7):2105-12. PubMed ID: 2317800
[TBL] [Abstract][Full Text] [Related]
3. Cytoskeletal organization in tropomyosin-mediated reversion of ras-transformation: Evidence for Rho kinase pathway.
Shah V; Bharadwaj S; Kaibuchi K; Prasad GL
Oncogene; 2001 Apr; 20(17):2112-21. PubMed ID: 11360195
[TBL] [Abstract][Full Text] [Related]
4. Suppression of src-induced transformed phenotype by expression of tropomyosin-1.
Prasad GL; Masuelli L; Raj MH; Harindranath N
Oncogene; 1999 Mar; 18(11):2027-31. PubMed ID: 10208425
[TBL] [Abstract][Full Text] [Related]
5. Suppression of the transformed phenotype of breast cancer by tropomyosin-1.
Mahadev K; Raval G; Bharadwaj S; Willingham MC; Lange EM; Vonderhaar B; Salomon D; Prasad GL
Exp Cell Res; 2002 Sep; 279(1):40-51. PubMed ID: 12213212
[TBL] [Abstract][Full Text] [Related]
6. Resensitization of breast cancer cells to anoikis by tropomyosin-1: role of Rho kinase-dependent cytoskeleton and adhesion.
Bharadwaj S; Thanawala R; Bon G; Falcioni R; Prasad GL
Oncogene; 2005 Dec; 24(56):8291-303. PubMed ID: 16170368
[TBL] [Abstract][Full Text] [Related]
7. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.
Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E
Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564
[TBL] [Abstract][Full Text] [Related]
8. A novel splice variant of the beta-tropomyosin (TPM2) gene in prostate cancer.
Assinder SJ; Au E; Dong Q; Winnick C
Mol Carcinog; 2010 Jun; 49(6):525-31. PubMed ID: 20336778
[TBL] [Abstract][Full Text] [Related]
9. Loss of the expression of the tumor suppressor gene ARHI is associated with progression of breast cancer.
Wang L; Hoque A; Luo RZ; Yuan J; Lu Z; Nishimoto A; Liu J; Sahin AA; Lippman SM; Bast RC; Yu Y
Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3660-6. PubMed ID: 14506155
[TBL] [Abstract][Full Text] [Related]
10. Anti-oncogenic effects of tropomyosin: isoform specificity and importance of protein coding sequences.
Braverman RH; Cooper HL; Lee HS; Prasad GL
Oncogene; 1996 Aug; 13(3):537-45. PubMed ID: 8760295
[TBL] [Abstract][Full Text] [Related]
11. Tropomyosin-1, a novel suppressor of cellular transformation is downregulated by promoter methylation in cancer cells.
Bharadwaj S; Prasad GL
Cancer Lett; 2002 Sep; 183(2):205-13. PubMed ID: 12065096
[TBL] [Abstract][Full Text] [Related]
12. Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors.
Huang H; Groth J; Sossey-Alaoui K; Hawthorn L; Beall S; Geradts J
Clin Cancer Res; 2005 Jun; 11(12):4357-64. PubMed ID: 15958618
[TBL] [Abstract][Full Text] [Related]
13. Tumor suppressor tropomyosin Tpm2.1 regulates sensitivity to apoptosis beyond anoikis characterized by changes in the levels of intrinsic apoptosis proteins.
Desouza-Armstrong M; Gunning PW; Stehn JR
Cytoskeleton (Hoboken); 2017 Jun; 74(6):233-248. PubMed ID: 28378936
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of tropomyosin-1 in squamous cell carcinoma of esophagus, the role of Ras signaling and methylation.
Zare M; Jazii FR; Soheili ZS; Moghanibashi MM
Mol Carcinog; 2012 Oct; 51(10):796-806. PubMed ID: 22965424
[TBL] [Abstract][Full Text] [Related]
15. Tumor-specific RNAi targeting eIF4E suppresses tumor growth, induces apoptosis and enhances cisplatin cytotoxicity in human breast carcinoma cells.
Dong K; Wang R; Wang X; Lin F; Shen JJ; Gao P; Zhang HZ
Breast Cancer Res Treat; 2009 Feb; 113(3):443-56. PubMed ID: 18327707
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of geminin stimulates the growth of mammary epithelial cells and is a frequent event in human tumors.
Montanari M; Boninsegna A; Faraglia B; Coco C; Giordano A; Cittadini A; Sgambato A
J Cell Physiol; 2005 Jan; 202(1):215-22. PubMed ID: 15389519
[TBL] [Abstract][Full Text] [Related]
17. Overexpression and hyperactivity of breast cancer-associated fatty acid synthase (oncogenic antigen-519) is insensitive to normal arachidonic fatty acid-induced suppression in lipogenic tissues but it is selectively inhibited by tumoricidal alpha-linolenic and gamma-linolenic fatty acids: a novel mechanism by which dietary fat can alter mammary tumorigenesis.
Menendez JA; Ropero S; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Jun; 24(6):1369-83. PubMed ID: 15138577
[TBL] [Abstract][Full Text] [Related]
18. Loss of B-cell translocation gene-2 in estrogen receptor-positive breast carcinoma is associated with tumor grade and overexpression of cyclin d1 protein.
Kawakubo H; Brachtel E; Hayashida T; Yeo G; Kish J; Muzikansky A; Walden PD; Maheswaran S
Cancer Res; 2006 Jul; 66(14):7075-82. PubMed ID: 16849553
[TBL] [Abstract][Full Text] [Related]
19. Differential gene expression profile in breast cancer-derived stromal fibroblasts.
Singer CF; Gschwantler-Kaulich D; Fink-Retter A; Haas C; Hudelist G; Czerwenka K; Kubista E
Breast Cancer Res Treat; 2008 Jul; 110(2):273-81. PubMed ID: 17899370
[TBL] [Abstract][Full Text] [Related]
20. Regulation of the expression of tropomyosins and actin cytoskeleton by ras transformation.
Prasad GL
Methods Enzymol; 2006; 407():410-22. PubMed ID: 16757342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
